Vyas Ramanan
InvestorVenture Partner at Third Rock Ventures
East Coast
Writes $100K – $5M checks · typically $1.5M
About
Vyas Ramanan is a Venture Partner at Third Rock Ventures, which he joined in 2016, where he helps build new biotech companies at the intersection of biological insight and drug discovery technology to advance medicines for serious diseases. Early in his time at the firm he was involved in the launch of Maze Therapeutics and spent subsequent years helping build its team toward first-in-class medicines. He holds undergraduate and graduate degrees in bioengineering and economics from the University of Pennsylvania, and a Ph.D. from the Harvard-MIT Division of Health Sciences and Technology.
Contact· published on Vyas's own website
Beyond investing
- Education
- Earned a B.S. in Economics from the University of Pennsylvania. Earned a B.S.E. in Bioengineering from the University of Pennsylvania. Earned an M.S.E. in Bioengineering from the University of Pennsylvania. Earned a Ph.D. in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology.
- Hobbies
- Enjoys exploring new restaurants near and far. Is an avid coffee drinker. Likes giving dogs more attention than they want.
From Vyas's own website — common ground for a warm intro.
Experience
- Marea TherapeuticsDirectorcurrent2024 — present
- Third Rock VenturesVenture Partnercurrent2024 — present
- Third Rock VenturesPrincipal2020 — 2023
- Maze TherapeuticsR&D2018 — 2021San Francisco Bay Area
- Third Rock VenturesSenior Associate2016 — 2018San Francisco and Boston
- Institute for Medical Engineering and Science (IMES) at MITPhD Candidate, Laboratory for Multiscale Regenerative Technologies2011 — 2016
- University of PennsylvaniaResearch Assistant, Molecular Systems Biology Lab2010 — 2011
- University of PennsylvaniaGraduate Research Assistant, Polymeric Biomaterials Laboratory2009 — 2011
- University of PennsylvaniaResearch Assistant, Polymeric Biomaterials Laboratory2008 — 2009
- Lux CapitalSummer Associate2009
Skills & more
Entrepreneurship14Biomedical Engineering10Biotechnology27Biomaterials12Tissue Engineering7Virology1
From Vyas's professional profile.
Investments
Investor
Maze Therapeutics
Per the investor's own website.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Frequently asked questions
- Who is Vyas Ramanan?
- Vyas Ramanan is a Venture Partner at Third Rock Ventures, which he joined in 2016, where he helps build new biotech companies at the intersection of biological insight and drug discovery technology to advance medicines for serious diseases. Early in his time at the firm he was involved in the launch of Maze Therapeutics and spent subsequent years helping build its team toward first-in-class medicines. He holds undergraduate and graduate degrees in bioengineering and economics from the University of Pennsylvania, and a Ph.D. from the Harvard-MIT Division of Health Sciences and Technology.
- Where does Vyas Ramanan work?
- Vyas Ramanan is Venture Partner at Third Rock Ventures.
- What check size does Vyas Ramanan write?
- Vyas Ramanan typically writes checks of $100K – $5M.
- What companies has Vyas Ramanan invested in?
- Investments tracked here include Maze Therapeutics.
- Where did Vyas Ramanan go to school?
- Vyas Ramanan studied at Harvard-MIT Division of Health Sciences and Technology (PhD, Medical Engineering Medical Physics); University of Pennsylvania (MSE, Bioengineering); University of Pennsylvania (BSE, Bioengineering).
Same school
Also attended University of Pennsylvania824
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 818 more
Also attended The Wharton School1,557
Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of Atomic
+ 1,551 more
Shared employers
Also worked at Marea Therapeutics1
Also worked at Third Rock Ventures80
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock VenturesOlie LuchitskyInvestor at Third Rock Ventures
+ 74 more
Also worked at Maze Therapeutics5
Also worked at Institute for Medical Engineering and Science (IMES) at MIT479
Aileen LeeFounder & Managing Partner of Cowboy VenturesMatt HuangCo-founder and Managing Partner at ParadigmMichael TruellCo-founder & CEO of CursorRaquel UrtasunFounder & CEO of WaabiColin WebbFounder & CEO of Avatar RoboticsAdam BryCo-founder & CEO of Skydio
+ 473 more